Related Experiment Video
Updated: Sep 30, 2026

Transplantation of Cells Directly into the Kidney of Adult Zebrafish
Published on: May 18, 2011
Successful Combined Heart and Kidney Transplantation in Patient With Fabry's Disease: A Case Report
Navin Rajagopalan1, Donna R Dennis1, William O'Connor1
1University of Kentucky, Lexington, Kentucky.
Insights
Fabry disease, a genetic disorder causing organ damage, can be treated with combined heart and kidney transplants. This case shows successful long-term outcomes with enzyme replacement therapy post-transplant.
Area of Science:
- Genetics and Medicine
- Transplantation Surgery
- Metabolic Disorders
Background:
- Fabry disease is an X-linked genetic disorder.
- Glycosphingolipid accumulation leads to kidney and heart damage.
- Chronic renal failure and heart failure are severe complications.
Observation:
- A 62-year-old male with Fabry disease presented with advanced kidney and heart failure.
- The patient underwent a combined heart and kidney transplant.
- He received enzyme replacement therapy with recombinant human alpha-galactosidase A.
Findings:
- The patient achieved normal cardiac and renal function 7 years post-transplantation.
- Successful organ function was maintained with ongoing enzyme replacement therapy.
- Fabry disease did not preclude successful transplantation.
Implications:
- Combined heart and kidney transplantation is a viable option for advanced Fabry disease.
- Enzyme replacement therapy is crucial for long-term graft and patient survival.
- This case highlights the potential for successful organ transplantation in Fabry disease patients.
Abstract:
Fabry's disease is a X-linked hereditary disease that causes the accumulation of glycosphingolipids in tissues and organs, including the kidneys and heart. This can result in both chronic kidney disease and cardiac dysfunction, including arrhythmias and heart failure. We describe a case of a 62-year-old male with Fabry's disease undergoing successful combined heart and kidney transplantation for chronic renal failure and low-output systolic heart failure. The patient has normal cardiac function and normal renal function 7 years after transplantation, while being maintained on enzyme replacement therapy with recombinant human alpha-galactosidase A. Fabry's disease is not a contraindication for organ transplantation, even in patients presenting with both renal failure and heart failure.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure

